Trial intelligence / Profile preview

Dysport vs placebo and Botox for moderate to severe glabellar lines in Chinese adults

CTR20150032Phase 3Completed

Sponsor
Ipsen
Start
Feb 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of botulinum toxin type A in glabellar furrowing, sponsored by Ipsen. Started Feb 2015; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

glabellar furrowing

Beyond the preview

Go deeper on CTR20150032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call